Dow Up 0.11% Nasdaq Up 0.50%

Immune Pharmaceuticals, Inc. (IMNP)

-NasdaqCM
3.85 Up 0.01(0.26%) Aug 29, 3:59PM EDT
Prev Close:3.84
Open:3.88
Bid:3.68 x 100
Ask:3.85 x 100
1y Target Est:8.50
Beta:N/A
Next Earnings Date:N/A
Day's Range:3.65 - 3.88
52wk Range:1.15 - 5.65
Volume:69,005
Avg Vol (3m):71,875
Market Cap:62.94M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMNP

Key Statistics

Forward P/E (1 yr):55.00
P/S (ttm):2,989.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops targeted antibody therapeutics for the treatment of inflammatory diseases and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback